Each leaves a little trail showing the journey the little snowroller took. Each is entirely self-made, and happens when the wind is strong enough to start rolling patches of snow on top of itself!
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...
Several groups have raised concerns on SB 1979, contained under Committee Report 41, due to the alleged "inappropriate concepts" in the proposed legislation. Among their concerns are the supposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results